UnitedHealth (UNH) valuation

Run six valuation models on UnitedHealth with live data: DCF, Reverse DCF, Graham number, Monte Carlo, scenarios and sum-of-the-parts (NAV).

UNH
UNH

UnitedHealth

UNH · Healthcare

Current price

397,11 USD

𝕏 Share on X
You're trying every model for free, no account needed. Sign up to save your analyses →

Valuation

Market cap
355.82 B USD
PE (TTM | NTM | +1y)
22.67 | 17.02 | 17.02
Price / Sales
0.79
EV / EBITDA
14.62
Price / Book
3.63

Cash flow

FCF yield(29.58 / 397.11)
+7.45%
SBC-adjusted FCF yield
—
SBC impact
—

Margins & growth

Profit margin
+3.53%
Operating margin
+5.85%
Quarterly earnings (YoY)
—
Quarterly revenue (YoY)
—

Balance

Cash
28.55 B USD
Debt
74.33 B USD
Net position
-45.78 B USD

Dividend

Dividend yield
+2.25%
Payout ratio
+51.71%
Next payout
12/15/2026

Price (5 years)

-9.48%
615.81 USD

What the market paid for its earnings

P/E (TTM)22.7×
203040Its own median 25.3×Its own mean 26.2×20212026

Each week's price divided by the earnings per share already reported by that date — four quarters where a company reports them, its last full year otherwise. Loss-making weeks are not drawn. Both lines are the company's own: the median is where it traded in half its weeks, the mean is where the extremes pull that average to. A mean well above the median means the high ratings were occasional rather than usual.

What the market paid for the year ahead

Forward P/E17.1×
2040Its own median 22.3×Its own mean 25.7×20212026

Each week's price divided by the earnings of the year still ahead of it. Those years have since happened, so this is the multiple paid against the figure that landed: nobody records what analysts expected at the time. The most recent stretch uses today's consensus. Both lines are the company's own: the median is where it traded in half its weeks, the mean is where the extremes pull that average to. A mean well above the median means the high ratings were occasional rather than usual.

What analysts expect

Consensus revenue and earnings per share for the periods not yet reported.

Revenue forecast

ReportedEstimate
050B100BQ4 25: 113.22 B USDQ4 25Q1 26: 111.72 B USDQ1 26Q2 26: 112.03 B USDQ2 26Q3 26: 112.69 B USDQ3 26Q4 26 · Estimate: 112.42 B USD (109.12 B USD – 115.40 B USD)Q4 26Q1 27 · Estimate: 113.70 B USD (109.70 B USD – 117.62 B USD)Q1 27USD

Consensus of 17 analysts for Q4 26 · -0.7% year on year

EPS forecast

ReportedEstimate
02.557.5Q4 25: 2.11 · expected 2.11 (+0.19%)Q4 25Q1 26: 7.23 · expected 6.60 (+9.52%)Q1 26Q2 26: 6.38 · expected 4.92 (+29.8%)Q2 26Q3 26: 4.69 · expected 4.14 (+13.26%)Q3 26Q4 26 · Estimate: 2.27 (2.15 – 2.62)Q4 26Q1 27 · Estimate: 8.17 (6.53 – 9.06)Q1 27

Consensus of 22 analysts for Q4 26 · +7.71% year on year · adjusted earnings

Analyst consensus from Yahoo Finance. The dashed bar is the average and the whisker runs from the lowest analyst to the highest. On periods already reported, the green or red line marks what had been expected: below the bar means the company beat it. EPS is measured on an adjusted basis, which is what analysts forecast against and is not the accounting profit in the statements.

Revenue

estimate
050B100BQ3 23: 92.36 B USDQ3 23Q4 23: 94.43 B USDQ1 24: 99.80 B USDQ1 24Q2 24: 98.86 B USDQ3 24: 100.82 B USDQ3 24Q3 25: 113.16 B USDQ4 25: 113.22 B USDQ4 25Q1 26: 111.72 B USDQ2 26: 112.03 B USDQ3 26: 112.69 B USDQ3 26Q4 26 · estimate: 112.42 B USDQ4 26USD

EBITDA

03B5B8BQ3 23: 9.53 B USDQ3 23Q4 23: 8.66 B USDQ1 24: 8.93 B USDQ1 24Q2 24: 8.90 B USDQ3 24: 9.75 B USDQ3 24Q3 25: 5.33 B USDQ4 25: 1.37 B USDQ4 25Q1 26: 9.95 B USDQ2 26: 8.97 B USDQ3 26: 7.56 B USDQ3 26USD

Net income

02B4B6BQ3 23: 5.84 B USDQ3 23Q4 23: 5.46 B USDQ1 24: -1.41 B USDQ1 24Q2 24: 4.22 B USDQ3 24: 6.06 B USDQ3 24Q3 25: 2.35 B USDQ4 25: 10.00 M USDQ4 25Q1 26: 6.28 B USDQ2 26: 5.48 B USDQ3 26: 4.11 B USDQ3 26USD

Free cash flow

-5B05B10BQ3 23: 6.06 B USDQ3 23Q4 23: -6.15 B USDQ1 24: 401.00 M USDQ1 24Q2 24: 5.89 B USDQ3 24: 12.95 B USDQ3 24Q3 25: 5.06 B USDQ4 25: 160.00 M USDQ4 25Q1 26: 8.15 B USDQ2 26: 10.25 B USDQ3 26: 4.26 B USDQ3 26USD

EPS

02.55Q3 23: 6.24Q3 23Q4 23: 5.85Q1 24: -1.53Q1 24Q2 24: 4.54Q3 24: 6.51Q3 24Q3 25: 2.59Q4 25: 0.01Q4 25Q1 26: 6.90Q2 26: 6.04Q3 26: 4.56Q3 26

Cash & debt

CashDebt
025B50B75BQ3 23 · Cash: 38.92 B USDQ3 23Q4 23 · Cash: 25.43 B USDQ1 24 · Cash: 28.41 B USDQ1 24Q2 24 · Cash: 26.29 B USDQ3 24 · Cash: 32.40 B USDQ3 24Q3 25 · Cash: 27.21 B USDQ3 25 · Debt: 80.14 B USDQ4 25 · Cash: 24.37 B USDQ4 25 · Debt: 78.39 B USDQ4 25Q1 26 · Cash: 28.00 B USDQ1 26 · Debt: 77.92 B USDQ2 26 · Cash: 28.59 B USDQ2 26 · Debt: 73.33 B USDQ3 26 · Cash: 25.85 B USDQ3 26 · Debt: 74.33 B USDQ3 26USD

Return of capital

DividendsBuybacks
02B4BQ3 23 · Dividends: 1.74 B USDQ3 23 · Buybacks: 1.50 B USDQ3 23Q4 23 · Dividends: 1.74 B USDQ4 23 · Buybacks: 1.50 B USDQ1 24 · Dividends: 1.73 B USDQ1 24 · Buybacks: 3.07 B USDQ1 24Q2 24 · Dividends: 1.94 B USDQ2 24 · Buybacks: 0.00 USDQ3 24 · Dividends: 1.94 B USDQ3 24 · Buybacks: 956.00 M USDQ3 24Q3 25 · Dividends: 2.00 B USDQ4 25 · Dividends: 2.00 B USDQ4 25Q1 26 · Dividends: 2.01 B USDQ2 26 · Dividends: 2.09 B USDQ2 26 · Buybacks: 1.65 B USDQ3 26 · Dividends: 2.08 B USDQ3 26 · Buybacks: 3.39 B USDQ3 26USD

Stock-based compensation

0100M200M300MQ3 23: 247.00 M USDQ3 23Q4 23: 208.00 M USDQ1 24: 372.00 M USDQ1 24Q2 24: 222.00 M USDQ3 24: 237.00 M USDQ3 24Q3 25: 223.00 M USDQ4 25: 176.00 M USDQ4 25Q1 26: 348.00 M USDQ2 26: 276.00 M USDQ3 26: 219.00 M USDQ3 26USD

Operating expenses

R&DSG&A
05B10BQ3 23 · SG&A: 13.86 B USDQ3 23Q4 23 · SG&A: 13.34 B USDQ4 23Q1 24 · SG&A: 14.08 B USDQ1 24Q2 24 · SG&A: 13.16 B USDQ2 24Q3 24 · SG&A: 13.28 B USDQ3 24USD

Source: Yahoo Finance. Quarterly history grows automatically over time as new quarters are published.

Other comparisons

Popular companies